Drug & intervention

sotatercept

RxCUI 2678930

Clinical trials10
Recruiting4
Related conditions7
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

10 shown
A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator TherapyNCT07356778 · 2025-10-07
RECRUITING
Sotatercept in Pulmonary Arterial HypertensionNCT07140484 · 2025-10-06
RECRUITING
Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE)NCT06658522 · 2025-05-14
RECRUITING
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)NCT05587712 · 2023-01-19
RECRUITING
SIRIUS - Initial Combination Therapy With an Endothelin Receptor Antagonist, a Phosphodiesterase-5 Inhibitor and Sotatercept in Patients With Newly Diagnosed Pulmonary Arterial HypertensionNCT07266519 · 2026-07-01
NOT_YET_RECRUITING
Sotatercept on Central Cardiopulmonary Performance and Peripheral Oxygen Transport During Exercise in Pulmonary Arterial HypertensionNCT06409026 · 2024-07-05
COMPLETED
Pulmonary Hypertension: Intensification and Personalisation of Combination RxNCT05825417 · 2023-06-14
ACTIVE_NOT_RECRUITING
Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13)NCT04811092 · 2022-03-18
TERMINATED
A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)NCT04896008 · 2021-12-01
COMPLETED
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)NCT03496207 · 2018-06-13
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.